Private Equity

Updated:

Nordic Science Investments

Nordic Science is a Helsinki-based venture capital firm. It partners with university research teams to commercialize scientific discoveries, providing...

Nordic Science Investments logo

Nordic Science Investments

Nordic Science is a Helsinki-based venture capital firm. It partners with university research teams to commercialize scientific discoveries, providing financial capital and resources. The firm has made 24 investments, including a Seed VC investment in CubaseBio on February 17, 2026.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Finland

City

Helsinki

Corporate office

Helsinki, Finland

Principals

Alexandra Gylfe

Founding Partner

Jari Strandman

Founding Partner

Gerard de Bourbon

Partner

Mart Maasik

Partner

Sector focus

Deep TechHealth TechLife Sciences

Frequently asked questions

How does Nordic Science Investments source its startup pipeline?

NSI partners directly with university innovation offices and tech-transfer teams across the New Nordics, evaluating IP before formal spinout. This integration with academic screening processes gives the firm early visibility on commercialization-ready research, rather than relying solely on inbound founder pitches.

What is the relationship between Nordic Science Investments and SmartCap?

In December 2025, SmartCap Venture Capital Fund — a state-backed Estonian fund-of-funds — invested €3 million into NSI (per firm website, December 2025). The commitment is designed to strengthen early-stage deep-tech investment across Estonia and the wider Baltic-Nordic corridor.

What investment stages does NSI typically target?

NSI’s sweet spot is pre-seed, where it anchors university spinouts with €50–100k tickets. The firm provides full follow-on capacity through Series B, scaling its checks to €400–600k at seed, €1–1.5M at Series A, and up to €3.5M for later rounds (per firm website).

Which sectors does Nordic Science Investments explicitly avoid?

The firm concentrates exclusively on deeptech, healthtech, and life sciences. Consumer internet, enterprise SaaS without hard-science moats, and capital-light service businesses are not part of the mandate.

Does NWI operate solely in Finland, or does it have a broader geographic footprint?

While headquartered in Helsinki, NSI’s investment scope covers what it calls the 'New Nordics,' with active portfolio companies in Estonia and Finland. The addition of Estonian-based Partner Mart Maasik and the SmartCap relationship reinforce the multi-country strategy.

What is the firm's known posture on co-investments alongside external VCs?

NSI actively co-invests, positioning itself as a deal anchor for other funds. It has publicly referenced a partnership with Taaleri and notes that co-investors are welcome at the seed round, with the aim of de-risking startups for follow-on institutional capital.

Who makes the final investment decisions at Nordic Science Investments?

The firm does not publicly disclose its investment committee structure, but the four named partners — Alexandra Gylfe, Jari Strandman, Gerard de Bourbon, and Mart Maasik — collectively represent the senior deal-making layer as listed on the firm's contact page.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Helsinki Private Equity profiles